EyeGate Pharmaceuticals Inc (EYEG):企業の財務・戦略的SWOT分析

◆英語タイトル:EyeGate Pharmaceuticals Inc (EYEG) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME16499FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical and drug delivery company that develops and commercializes products for treating diseases and disorders of the eye. The company’s proprietary technology EyeGate II delivery system, utilizes transscleral iontophoresis to deliver optimal therapeutic levels of drug directly into the targeted ocular tissue; and CMHA-S platform is based on hyaluronic acid used in physiological processes such as development, wound healing, tissue homeostasis and joint lubrication. EyeGate’s EGP-437, product in clinical trials, incorporates a reformulated corticosteroid, dexamethasone phosphate which is delivered into the ocular tissues. It also offers drug delivery mechanisms for treating diseases of the eye. EyeGate is headquartered in Waltham, Massachusetts, the US.

EyeGate Pharmaceuticals Inc Key Recent Developments

Apr 01,2021: EyeGate Pharma Announces the Appointment of Kenneth Gayron and Aron Shapiro to its Board of Directors
Mar 25,2021: EyeGate Pharma Reports Full Year 2020 Financial Results and Provides Business Update
Feb 01,2021: L2 : Alliances and Partnerships : EyeGate Pharmaceuticals Announces Management Transition In Support of Strategic Transformation

This comprehensive SWOT profile of EyeGate Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of EyeGate Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

EyeGate Pharmaceuticals Inc – Key Information
EyeGate Pharmaceuticals Inc – Overview
EyeGate Pharmaceuticals Inc – Key Employees
EyeGate Pharmaceuticals Inc – Key Employee Biographies
EyeGate Pharmaceuticals Inc – Key Operational Heads
EyeGate Pharmaceuticals Inc – Major Products and Services
EyeGate Pharmaceuticals Inc – History
EyeGate Pharmaceuticals Inc – Company Statement
EyeGate Pharmaceuticals Inc – Locations And Subsidiaries
EyeGate Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

EyeGate Pharmaceuticals Inc – Business Description
EyeGate Pharmaceuticals Inc – Corporate Strategy
EyeGate Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
EyeGate Pharmaceuticals Inc – Strengths
EyeGate Pharmaceuticals Inc – Weaknesses
EyeGate Pharmaceuticals Inc – Opportunities
EyeGate Pharmaceuticals Inc – Threats
EyeGate Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

EyeGate Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

EyeGate Pharmaceuticals Inc, Key Information
EyeGate Pharmaceuticals Inc, Key Ratios
EyeGate Pharmaceuticals Inc, Share Data
EyeGate Pharmaceuticals Inc, Major Products and Services
EyeGate Pharmaceuticals Inc, History
EyeGate Pharmaceuticals Inc, Key Employees
EyeGate Pharmaceuticals Inc, Key Employee Biographies
EyeGate Pharmaceuticals Inc, Key Operational Heads
EyeGate Pharmaceuticals Inc, Other Locations
EyeGate Pharmaceuticals Inc, Subsidiaries
EyeGate Pharmaceuticals Inc, Key Competitors
EyeGate Pharmaceuticals Inc, SWOT Analysis
EyeGate Pharmaceuticals Inc, Ratios based on current share price
EyeGate Pharmaceuticals Inc, Annual Ratios
EyeGate Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[EyeGate Pharmaceuticals Inc (EYEG):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Checkpoint Systems, Inc.:企業の戦略・SWOT・財務情報
    Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Advanced Electronics Company:企業の戦略・SWOT・財務情報
    Advanced Electronics Company - Strategy, SWOT and Corporate Finance Report Summary Advanced Electronics Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Obuv Rossii OOO (OBUV):企業の財務・戦略的SWOT分析
    Obuv Rossii OOO (OBUV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Virgin Group Ltd.:企業の戦略・SWOT・財務情報
    Virgin Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Virgin Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Media General, Inc.:企業のM&A・事業提携・投資動向
    Media General, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Media General, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • The Dow Chemical Co-エネルギー分野:企業M&A・提携分析
    Summary The Dow Chemical Company (Dow), a subsidiary of DowDupont is a diversified chemical company. Its businesses encompass specialty chemicals, advanced materials, agrosciences and plastics. The company manufactures and supplies products used primarily as raw materials in the manufacture of custo …
  • Institute for Molecular Medicine Finland:製薬・医療:M&Aディール及び事業提携情報
    Summary Institute for Molecular Medicine Finland (FIMM) is a research institute that conducts research activities in the fields of human genomics and personalized medicine. The institute develops diagnostics, treatment and prevention of common health problems using Finnish clinical and epidemiologic …
  • Knight Therapeutics Inc (GUD):医療機器:M&Aディール及び事業提携情報
    Summary Knight Therapeutics Inc (Knight Therapeutics) is a specialty pharmaceutical company focused on acquisition, licensing, marketing and distribution of prescription, consumer health products and medical devices. Its consumer health products are used in the treatment of metabolic diseases, derma …
  • Armada Hoffler Properties Inc:企業の戦略・SWOT・財務分析
    Armada Hoffler Properties Inc - Strategy, SWOT and Corporate Finance Report Summary Armada Hoffler Properties Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Eaton Corporation Plc (ETN):企業の財務・戦略的SWOT分析
    Eaton Corporation Plc (ETN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Zafgen Inc (ZFGN):企業の財務・戦略的SWOT分析
    Summary Zafgen Inc (Zafgen) is a clinical-stage biopharmaceutical company that develops transformative therapies for patients affected by a range of metabolic diseases. Its pipeline product portfolio includes ZGN-1061, a small molecule MetAP2 inhibitor being developed for patients with type 2 diabet …
  • Pharma Two B Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharma Two B Ltd (Pharma Two) is a drug development company that develops and manufactures drugs for the treatment of Parkinson's disease and cancer. The company provides combination products in preclinical state and generic products including P2B 005, P2B 006, P2B 007, P2B 008 and P2B 009, …
  • Vysarn Ltd (MHM):企業の戦略的SWOT分析
    Vysarn Ltd (MHM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Etablissementen Franz Colruyt NV (COLR):企業の財務・戦略的SWOT分析
    Etablissementen Franz Colruyt NV (COLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Myriad RBM Inc-医療機器分野:企業M&A・提携分析
    Summary Myriad RBM Inc (Myriad RBM), formerly Rules Based Medicine Inc, a subsidiary of Myriad Genetics Inc, is an immunoassay testing laboratory that provides protein biomarker products and services. The company’s products and services include HumanMAP services that assist investigators in the disc …
  • Robert Half International Inc.:企業の戦略・SWOT・財務情報
    Robert Half International Inc. - Strategy, SWOT and Corporate Finance Report Summary Robert Half International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Atopix Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Atopix Therapeutics Ltd (Atopix) is a clinical stage biotechnology company that develops novel treatments for Th2-mediated eosinophilic asthma. The company’s product portfolio includes CRTH2 used in the treatment of atopic dermatitis. It also offers ATX2417 and OC459 used in treatment of ast …
  • EKF Diagnostics Holdings Plc (EKF)-医療機器分野:企業M&A・提携分析
    Summary EKF Diagnostics Holdings Plc (EKF Diagnostics) is a medical device company which designs, develops, manufactures, and commercializes chemical reagents, and analyzers for the measurement of glucose, lactate, hematocrit, hemoglobin, and glycated hemoglobin. The company’s product portfolio comp …
  • Heerema International Group Services SA:企業の戦略的SWOT分析
    Heerema International Group Services SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • bioLytical Laboratories Inc:企業の製品パイプライン分析
    Summary bioLytical Laboratories Inc (bioLytical) operates as a medical device company that develops and manufactures HIV diagnostic products. The company provides products such as insti HIV-1 and HIV-2 antibody test and insti HIV-1 and HIV-2 test controls. Its product line offers test result that tr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆